This is a service / maintenance or supply contract in Irvine, California. Contact the soliciting agency for additional information.

Amendment Two is for the following reason(s): The response date is extended to by 4:00 PM EDT on July 26, 2024. Added Attachment 18 Amendment Two Questions and Answers 07162024 Added Attachment 15 Site Roster LOSDO Jun 27, 2024, Rev 1 Added Attachment 8 Pricing Table Revision is found on Table "Task Orde One" added Unite Price Column and Unit of Issue (Monthly) Column. Added Attachment 19 SF 30 Amendment Two Added CB Synopsis Sol 75F40124R00001_A0002 07162024 All amendment two Changes are in dark red. All other terms and conditions remain the same. **************************************************************************************** This is a combined synopsis/solicitation for commercial services prepared in accordance with the Federal Acquisition Regulation (FAR) format Subpart 12.6 and additional information included in this notice. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2024-05. THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION AND A SEPARATE SOLICITATION WILL NOT BE ISSUED. The solicitation number for this acquisition is 75F40124R00001 and is being issued as a Request for Proposal(RFP). The associated North American Industry Classification System (NAICS) Code for this solicitation is 561210, Industry Description: Facilities Support Services, and Size Standard: $47 million. This requirement is an 8(a) Small Business Administration (SBA) Set-Aside Competitive procurement. Prospective Offerors are responsible for downloading the solicitation and any amendments. The Government reserves the right to award an order without discussions if the Contracting Officer determines that the initial offer is providing best value and discussions are not necessary. See attached Combined Synopsis/Solicitation, Attachments, and Amendments in full text. : Interested Offerors shall submit questions electronically to Patricia.Natividad@fda.hhs.gov no later than June 28, 2024, 2 p.m.. ET. Please include the company name, FDA solicitation number, and "Question(s)" in the subject line.